Ivana Stojanovic is the Vice President of Market Access and Direct to Consumer Marketing at CVRx. Prior to CVRx, Ivana worked a strategic consultant and as an economist across multiple verticals within the pharmaceutical and medical device industries. CVRx is a medical manufacturer out of Minnesota, develops, manufactures and commercializes Barostim, an innovative extravascular implantable neuromodulation device for patients with cardiovascular diseases. Barostim is the first medical technology approved by FDA that uses autonomic nervous system to improve the symptoms of patients with heart failure.